MAPK1 and type 2 diabetes mellitus: The results suggest that activities of extracellular signal-regulated kinase (ERK) and JNK were significantly increased in T2DM mice compared with the control group, but their activities reversed back to the normal level similar to those in control group mice after Zonisamide treatment (Figures 5B,D).